AtaiBeckley (ATAI) Interest & Investment Income (2020 - 2026)
AtaiBeckley's quarterly Interest & Investment Income came in at $78000.0 in Q1 2026, down 58.06% year-on-year from $186000.0 in Q1 2025, and down 58.06% quarter-over-quarter from $186000.0 in Q1 2025.
AtaiBeckley's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $504000.0 for Q3 2025.
- In Q3 2025, Interest & Investment Income rose 215.0% year-over-year to $504000.0; the TTM figure through Sep 2025 stood at $1.1 million (down 8.86% YoY), while the FY2024 annual figure was $778000.0, down 57.88% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $78000.0, down from $186000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $186000.0 in Q1 2025, with the low at $78000.0 in Q1 2026.
- A 5-year average of $227052.6 and a median of $186000.0 in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 1712.5% in 2022 and slumped 73.86% in 2024, its largest moves.
- AtaiBeckley's Interest & Investment Income stood at $125000.0 in 2021, then soared by 49.6% to $187000.0 in 2022, then surged by 250.8% to $656000.0 in 2023, then sank by 70.58% to $193000.0 in 2024, then soared by 161.14% to $504000.0 in 2025.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $504000.0, $248000.0, and $186000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | AtaiBeckley | 1.62 Bn | 1.62 Bn | - | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,000.00 |
| Sep 30, 2025 | 504,000.00 |
| Jun 30, 2025 | 248,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 160,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Mar 31, 2024 | 307,000.00 |
| Dec 31, 2023 | 656,000.00 |
| Sep 30, 2023 | 612,000.00 |
| Jun 30, 2023 | 303,000.00 |
| Mar 31, 2023 | 275,000.00 |
| Dec 31, 2022 | 187,000.00 |
| Sep 30, 2022 | 145,000.00 |
| Jun 30, 2022 | 117,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 35,000.00 |
| Mar 31, 2021 | 37,000.00 |
| Dec 31, 2020 | 14,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Jun 30, 2020 | 18,000.00 |